Navigation Links
Enlisting a drug discovery technique in the battle against global warming
Date:2/3/2010

Scientists in Texas are reporting that a technique used in the search for new drugs could also be used in the quest to discover new, environmentally friendly materials for fighting global warming. Such materials could be used to capture the greenhouse gas carbon dioxide from industrial smokestacks and other fixed sources before it enters the biosphere. The new study appears in ACS' bi-monthly journal Energy & Fuels.

Michael Drummond and colleagues Angela Wilson and Tom Cundari note that greener carbon-capture technologies are a crucial component in mitigating climate change. Existing technology is expensive and can generate hazardous waste. They point out that proteins, however, can catalyze reactions with carbon dioxide, the main greenhouse gas, in an environmentally friendly way. That fact got the scientists interested in evaluating the possibility of using proteins in carbon capture technology.

In the study, they used the pharmacophore concept to probe how the 3-dimensional structure of proteins affects their ability to bind and capture carbon dioxide. The German chemist and Nobel Laureate Paul Ehrlich, who originated the concept a century ago, defined a pharmacophore as the molecular framework that carries the key features responsible for a drug's activity. The scientists concluded that the approach could point the way to the development of next-generation carbon capture technologies.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert  

Page: 1

Related biology news :

1. TGen becomes center of excellence for Horizon Discoverys GENESIS and X-MAN technology
2. Gene function discovery: Guilt by association
3. Discovery of algaes toxic hunting habits could help curb fish kills
4. From biological basics to diabetes discovery
5. Game-changing nanodiamond discovery for MRI
6. Discovery points toward anti-inflammation treatment for blinding disease
7. Discovery at JGH opens door to new treatments for prostate, brain and skin cancers
8. Discovery of a new molecular mechanism that guides visual nerves towards the brain
9. New discovery by Harvard scientists aims to correct cellular defects leading to diabetes
10. New year, new vitamin C discovery: It cures mice with accelerated aging disease
11. Emerald BioStructures announces discovery of small molecule modulators of PDE4
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Enlisting a drug discovery technique in the battle against global warming
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Caris Life Sciences, ... Lustgarten Foundation, the largest private funder of pancreatic ... trial evaluating the impact of immunotherapy in the ... trial enrollment services to identify potential trial candidates ... between treating physicians and study investigators. The Lustgarten ...
(Date:1/17/2017)... ... 17, 2017 , ... LGC Maine Standards is ... calibration verification / linearity test kit. VALIDATE® SP2 evaluates Albumin, C-reactive protein, Haptoglobin, ... is prepared using the CLSI recommended “equal delta” method for linearity testing and ...
(Date:1/17/2017)... , Jan. 17, 2017  An international team ... Medicine and St. Boniface Hospital Albrechtsen Research Centre/University ... neuropathy, an unmet health need affecting nearly one ... of Clinical Investigation, their results identify small molecule ... and reverse neuronal injury in animal models of ...
(Date:1/17/2017)... Mass. , Jan. 17, 2017   Pulmatrix, ... stage biopharmaceutical company developing innovative inhaled therapies to address ... for treating fungal infections in the lungs of CF ... Disease Product" (QIDP) by the U.S. Food & Drug ... which is designed to speed the development of novel ...
Breaking Biology Technology: